Our Take
China just weaponized M&A approval as an AI export control, signaling that strategic AI talent is now treated like military technology.
Why it matters
Western tech companies with Chinese AI acquisition targets now face regulatory veto power from Beijing, while Chinese AI startups lose a major exit pathway. The move escalates beyond trade restrictions into direct investment blocking.
Do this week
M&A teams: Audit pending deals involving Chinese AI assets before Q2 earnings calls so you can flag new regulatory risk to boards.
Beijing vetoes Meta's Manus deal
Chinese regulators blocked Meta's $2 billion acquisition of AI startup Manus, citing national security grounds (per WSJ reporting). Beijing characterized the deal as a "conspiratorial" attempt to hollow out China's technology base (per Financial Times). The decision represents China's first major use of M&A approval power to block a Western tech acquisition of a domestic AI company.
The move comes as China tightens restrictions on AI firms attempting to relocate or sell to foreign buyers (per TechCrunch). Regulators appear to be treating AI talent and intellectual property as strategic assets requiring protection from foreign acquisition.
Export controls expand to M&A approval
The Manus blocking signals China's shift from passive trade restrictions to active investment interference. While the US has blocked Chinese acquisitions of American AI companies for years, China's reciprocal action creates a new bilateral barrier to tech M&A. Western companies now face regulatory veto power from Beijing on deals involving Chinese AI assets.
Chinese AI startups lose a critical exit pathway just as venture funding becomes scarcer. The policy creates a trapped market for Chinese AI companies seeking Western buyers, potentially forcing them to accept lower valuations from domestic acquirers or remain private longer.
Legal and strategic implications
M&A teams need to reassess deal pipelines involving Chinese AI targets. Regulatory approval timelines will extend significantly, and approval probability drops for any deal Beijing views as strategically sensitive. Due diligence must now include detailed assessment of target companies' AI capabilities and their classification under China's national security framework.
The decision escalates US-China AI rivalry beyond export controls into direct investment blocking (per Bloomberg). Companies with significant Chinese AI operations should prepare for increased scrutiny of both acquisitions and divestitures. Cross-border AI deals now require political risk assessment alongside traditional commercial due diligence.